Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Centessa Pharmaceuticals plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +4 vs. Q2 2023
- Shares held
- 72.6M
- +2.24M (+3.2%) vs. Q2 2023
- Total value
- $469.6M
- +$34.2M (+7.8%) vs. Q2 2023
- New holders
- 5
- 17 more added
- Sold out
- 1
- 11 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 20 | $0 | 0.00% | −165−89.2% | Reduced |
| NBC Securities, Inc. | 138 | $0 | 0.00% | +138 | New |
| Qube Research & Technologies Ltd | 69 | $446 | 0.00% | +69 | New |
| Daiwa Securities Group Inc. | 211 | $1.00K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 700 | $4.12K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 656 | $4.24K | 0.00% | −239−26.7% | Reduced |
| Adirondack Trust Co | 925 | $5.98K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,357 | $8.78K | 0.00% | +666+96.4% | Added |
| UBS Group AG | 2,636 | $17.1K | 0.00% | +518+24.5% | Added |
| Advisor Group Holdings, Inc. | 2,813 | $18.2K | 0.00% | −363−11.4% | Reduced |
| Citadel Advisors LLC | 3,019 | $19.5K | 0.00% | −1,086−26.5% | Reduced |
| Tower Research Capital LLC (TRC) | 3,066 | $19.8K | 0.00% | −1,206−28.2% | Reduced |
| Compagnie Lombard Odier SCmA | 5,820 | $37.7K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,400 | $41.4K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 10,101 | $65.4K | 0.00% | −49,263−83.0% | Reduced |
| Goldman Sachs Group Inc | 10,650 | $68.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 11,600 | $75.1K | 0.00% | +500+4.5% | Added |
| Rathbone Brothers plc | 31,300 | $202.5K | 0.00% | +31,300 | New |
| Geode Capital Management, LLC | 31,833 | $206.0K | 0.00% | +6,713+26.7% | Added |
| Bank of America Corp | 51,943 | $336.1K | 0.00% | +47,732+1,133.5% | Added |
| Renaissance Technologies LLC | 53,100 | $344.0K | 0.00% | +18,800+54.8% | Added |
| Manufacturers Life Insurance Company, The | 63,021 | $407.7K | 0.00% | +5,600+9.8% | Added |
| Ensign Peak Advisors, Inc | 125,157 | $809.8K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 186,310 | $1.21M | 0.00% | +104,255+127.1% | Added |
| Woodline Partners LP | 210,204 | $1.36M | 0.02% | −477,559−69.4% | Reduced |
| Acuta Capital Partners, LLC | 323,349 | $2.09M | 1.52% | +323,349 | New |
| BlackRock Inc. | 325,843 | $2.11M | 0.00% | +31,343+10.6% | Added |
| Platinum Investment Management Ltd | 337,544 | $2.18M | 0.09% | +165,919+96.7% | Added |
| Octagon Capital Advisors LP | 475,600 | $3.08M | 0.54% | +63,672+15.5% | Added |
| Cormorant Asset Management, LP | 561,600 | $3.63M | 0.21% | 00.0% | Unchanged |
| American Century Companies Inc | 694,885 | $4.50M | 0.00% | +230.0% | Added |
| Tanager Wealth Management LLP | 696,096 | $4.50M | 0.93% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 730,472 | $4.73M | 0.79% | +1,395+0.2% | Added |
| Sio Capital Management, LLC | 756,891 | $4.90M | 1.52% | −120,302−13.7% | Reduced |
| Boxer Capital, LLC | 770,708 | $4.99M | 0.27% | −480,429−38.4% | Reduced |
| Franklin Resources Inc | 832,348 | $5.39M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 957,951 | $6.20M | 0.00% | +133,322+16.2% | Added |
| Affinity Asset Advisors, LLC | 1,018,091 | $6.59M | 2.15% | +117,368+13.0% | Added |
| Point72 Asset Management, L.P. | 1,840,482 | $11.9M | 0.04% | −170,906−8.5% | Reduced |
| TCG Crossover Management, LLC | 2,040,816 | $13.2M | 1.94% | +2,040,816 | New |
| Price T Rowe Associates Inc | 2,549,134 | $16.5M | 0.00% | +185,923+7.9% | Added |
| FMR LLC | 2,787,194 | $18.0M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,830,500 | $18.3M | 0.04% | +580,500+25.8% | Added |
| OUP Management Co., LLC | 2,937,615 | $19.0M | 42.74% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 3,931,818 | $25.4M | 39.38% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,618,779 | $36.4M | 1.24% | 00.0% | Unchanged |
| BVF Inc | 9,103,054 | $58.9M | 1.59% | −320,161−3.4% | Reduced |
| General Atlantic LLC | 9,681,818 | $62.6M | 0.97% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129.2M | 41.24% | 00.0% | Unchanged |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |